These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 10544257

  • 1. Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.
    Oscarson M, McLellan RA, Gullstén H, Agúndez JA, Benítez J, Rautio A, Raunio H, Pelkonen O, Ingelman-Sundberg M.
    FEBS Lett; 1999 Oct 29; 460(2):321-7. PubMed ID: 10544257
    [Abstract] [Full Text] [Related]

  • 2. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism.
    Oscarson M.
    Drug Metab Dispos; 2001 Feb 29; 29(2):91-5. PubMed ID: 11159795
    [Abstract] [Full Text] [Related]

  • 3. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population.
    Oscarson M, McLellan RA, Gullstén H, Yue QY, Lang MA, Bernal ML, Sinues B, Hirvonen A, Raunio H, Pelkonen O, Ingelman-Sundberg M.
    FEBS Lett; 1999 Apr 01; 448(1):105-10. PubMed ID: 10217419
    [Abstract] [Full Text] [Related]

  • 4. Determination of coumarin metabolism in Turkish population.
    Cok I, Aygün Kocabaş N, Cholerton S, Karakaya AE, Sardaş S.
    Hum Exp Toxicol; 2001 Apr 01; 20(4):179-84. PubMed ID: 11393269
    [Abstract] [Full Text] [Related]

  • 5. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase.
    Oscarson M, Gullstén H, Rautio A, Bernal ML, Sinues B, Dahl ML, Stengård JH, Pelkonen O, Raunio H, Ingelman-Sundberg M.
    FEBS Lett; 1998 Nov 06; 438(3):201-5. PubMed ID: 9827545
    [Abstract] [Full Text] [Related]

  • 6. Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype.
    Nunoya K, Yokoi T, Takahashi Y, Kimura K, Kinoshita M, Kamataki T.
    J Biochem; 1999 Aug 06; 126(2):402-7. PubMed ID: 10423536
    [Abstract] [Full Text] [Related]

  • 7. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.
    Fernandez-Salguero P, Hoffman SM, Cholerton S, Mohrenweiser H, Raunio H, Rautio A, Pelkonen O, Huang JD, Evans WE, Idle JR.
    Am J Hum Genet; 1995 Sep 06; 57(3):651-60. PubMed ID: 7668294
    [Abstract] [Full Text] [Related]

  • 8. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.
    Loriot MA, Rebuissou S, Oscarson M, Cenée S, Miyamoto M, Ariyoshi N, Kamataki T, Hémon D, Beaune P, Stücker I.
    Pharmacogenetics; 2001 Feb 06; 11(1):39-44. PubMed ID: 11207029
    [Abstract] [Full Text] [Related]

  • 9. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
    Fukami T, Nakajima M, Sakai H, McLeod HL, Yokoi T.
    Pharmacogenomics J; 2006 Feb 06; 6(6):401-12. PubMed ID: 16636685
    [Abstract] [Full Text] [Related]

  • 10. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.
    Rao Y, Hoffmann E, Zia M, Bodin L, Zeman M, Sellers EM, Tyndale RF.
    Mol Pharmacol; 2000 Oct 06; 58(4):747-55. PubMed ID: 10999944
    [Abstract] [Full Text] [Related]

  • 11. Novel human CYP2A6 alleles confound gene deletion analysis.
    Nakajima M, Yoshida R, Fukami T, McLeod HL, Yokoi T.
    FEBS Lett; 2004 Jul 02; 569(1-3):75-81. PubMed ID: 15225612
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms of CYP2A6 and its practical consequences.
    Raunio H, Rautio A, Gullstén H, Pelkonen O.
    Br J Clin Pharmacol; 2001 Oct 02; 52(4):357-63. PubMed ID: 11678779
    [Abstract] [Full Text] [Related]

  • 13. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M, Kwon JT, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, Yamazaki H, Yamamoto T, Kuroiwa Y, Yokoi T.
    Clin Pharmacol Ther; 2001 Jan 02; 69(1):72-8. PubMed ID: 11180041
    [Abstract] [Full Text] [Related]

  • 14. Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method.
    Paschke T, Riefler M, Schuler-Metz A, Wolz L, Scherer G, McBride CM, Bepler G.
    Toxicology; 2001 Nov 30; 168(3):259-68. PubMed ID: 11684323
    [Abstract] [Full Text] [Related]

  • 15. A novel single nucleotide polymorphism altering stability and activity of CYP2a6.
    Ariyoshi N, Sawamura Y, Kamataki T.
    Biochem Biophys Res Commun; 2001 Mar 02; 281(3):810-4. PubMed ID: 11237731
    [Abstract] [Full Text] [Related]

  • 16. 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression.
    Wang J, Pitarque M, Ingelman-Sundberg M.
    Biochem Biophys Res Commun; 2006 Feb 10; 340(2):491-7. PubMed ID: 16378601
    [Abstract] [Full Text] [Related]

  • 17. New CYP2A6 gene deletion and conversion variants in a population of Black African descent.
    Mwenifumbo JC, Zhou Q, Benowitz NL, Sellers EM, Tyndale RF.
    Pharmacogenomics; 2010 Feb 10; 11(2):189-98. PubMed ID: 20136358
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
    Oscarson M, McLellan RA, Asp V, Ledesma M, Bernal Ruiz ML, Sinues B, Rautio A, Ingelman-Sundberg M.
    Hum Mutat; 2002 Oct 10; 20(4):275-83. PubMed ID: 12325023
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk.
    Tyndale RF, Sellers EM.
    Drug Metab Dispos; 2001 Apr 10; 29(4 Pt 2):548-52. PubMed ID: 11259349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.